Glucagon-like peptide 1 receptor agonists (GLP-1RAs) are successful in treating type 2 diabetes mellitus and obesity. However, their use can increase the risk of regurgitation and pulmonary aspiration of gastric contents during sedation or general anesthesia.
Leave A Comment